Skip to content

menu

Rothwell, Figg, Ernst & Manbeck, P.C. logo
HomeAboutContact
RF EMerge logo

A Resource for Innovators

Topics

GuidanceTrends & AnalysisLegal DevelopmentsSubscribe
Photo of Andrew J. Storaska

Andrew J. Storaska

Follow: Read more about Andrew J. Storaska

The mRNA Patent and Competitive Landscape: Translate BIO; Arcturus; eTheRNA and Other Startups; and LNP Technology (Part II)

By Dan Shores, Dylan Haversack & Andrew J. Storaska on May 2, 2021
Posted in Featured, Trends & Analysis

In Part I of this three-part series, we focused on three mRNA technology market players: BioNTech, Moderna and CureVac.
Continue Reading The mRNA Patent and Competitive Landscape: Translate BIO; Arcturus; eTheRNA and Other Startups; and LNP Technology (Part II)

The mRNA Patent and Competitive Landscape Through One Year of the COVID-19 Pandemic–Part I

By Dan Shores, Dylan Haversack & Andrew J. Storaska on April 12, 2021
Posted in Featured, Trends & Analysis

Shortly after we posted about Moderna, Inc.’s October 2020 pledge not to enforce its COVID-19-related patents during the pandemic, the…
Continue Reading The mRNA Patent and Competitive Landscape Through One Year of the COVID-19 Pandemic–Part I

Rothwell, Figg, Ernst & Manbeck, P.C.
Subscribe to this Blog
New York
80 South Highland Ave
Ossining, NY 10562
914.941.5668
info@rfem.com
Washington, DC
607 14th St. NW
Suite 800
Washington, DC 20005
202.783.6040
info@rfem.com
Boston
10 Post Office Square
Suite 800
Boston, MA 02109
617.312.3101
info@rfem.com
RSS LinkedIn Twitter Facebook
Privacy PolicyDisclaimer

About Our Firm

To learn more about our firm and other practice areas, visit: www.rfem.com.

Rothwell Figg Blogs

  • Biosimilars Law Bulletin
  • Healthcare Marketing Law
  • Privacy Zone
  • PTAB Law Blog
  • Trademark Opposition Lawyer
Copyright © 2022, Rothwell, Figg, Ernst & Manbeck, P.C. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo

We use cookies to enhance your user experience. By continuing to use this site you are giving your consent for us to use cookies. For more information, please see our Privacy Policy.

Agree